NCT00084513 · Interventional trial
Trastuzumab and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic HER2/Neu-Expressing Cancer
Overall registry status Completed
Phase 1
Conditions Unspecified Adult Solid Tumor, Protocol Specific
Delaware Valley sites
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory